Filter your results
- 4
- 1
- 5
- 5
- 3
- 1
- 1
- 5
- 4
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 3
- 3
- 3
- 2
- 2
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
|
Risk Governance of Emerging Technologies Demonstrated in Terms of its Applicability to NanomaterialsSmall, 2020, 16 (36), pp.2003303. ⟨10.1002/smll.202003303⟩
Journal articles
anses-03081969v1
|
||
|
First expert elicitation of knowledge on possible drivers of observed increasing human cases of Tick-Borne Encephalitis in EuropeViruses, 2023, 15 (3), pp.791. ⟨10.3390/v15030791⟩
Journal articles
hal-04037581v1
|
||
|
Measuring DNA modifications with the comet assay: a compendium of protocolsNature Protocols, 2023, ⟨10.1038/s41596-022-00754-y⟩
Journal articles
hal-03997215v1
|
||
|
A strategy towards the generation of testable adverse outcome pathways for nanomaterialsAltex -Heidelberg-, 2021, pp.1-13. ⟨10.14573/altex.2102191⟩
Journal articles
anses-03278942v1
|
||
|
Linking nanomaterial-induced mitochondrial dysfunction to existing adverse outcome pathways for chemicalsALTEX - Alternatives to Animal Experimentation, In press, ⟨10.14573/altex.2305011⟩
Journal articles
anses-04199363v1
|